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The  objective  of this  study  is to evaluate  the  effects  of  chromic  chloride  (CrCl3)  on chick
embryo  ﬁbroblast  (CEF)  viability.  The  cells  were  incubated  with  CrCl3 (0.02,  0.1,  0.5, 2.5, 12.5,
and 62.5  M), and  the  viability  was  determined  using  MTT  assay,  morphological  detection
and  ﬂow  cytometry.  The  results  show  that  lower  concentrations  of CrCl3 (0.02,  0.1, and
0.5 M)  did not  damage  CEF  viability.  At  0.1  M, CrCl3 can  increase  CEF  viability  (P <  0.05).
However,  at  higher  concentrations  of  CrCl3 (2.5,  12.5,  and  62.5  M),  the  number  of  apoptotic
and  necrotic  cells  (P < 0.01)  and intracellular  reactive  oxygen  species  (P <  0.01)  increased.
In addition,  decreased  mitochondrial  membrane  potential  (P  <  0.01)  and  enhanced  intra-
cellular  calcium  levels  (P <  0.01)  were  observed  after  the  exposure.  Moreover,  apoptotic
morphological  changes  induced  by these  processes  in CEF  were  conﬁrmed  using  Hoechstlow cytometry 33258 staining.  Cell  death  induced  by  higher  concentrations  of CrCl3 was  caused  by  an
apoptotic  and  a necrotic  mechanism,  whereas  the main  mechanism  of oxidative  stress  and
induced  mitochondrial  dysfunction  was  apoptotic  death.  The  induced  apoptotic  death  in
CEF is  concentration-  and  time-dependent.
©  2015  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Chromium (Cr) is ubiquitous in the environment and
s naturally found in soils, rocks, and living organisms
1]. Chromium exists in different oxidation states from
2 to +6, of which Cr(III) and Cr(VI) are the two pri-
ary valence states that are widely used in industries [2].
side from causing allergic dermatitis and apoptotic cell
eath, Cr(VI) is also toxic, carcinogenic [3], and terato-
enic to animals and humans [3–6]. By contrast, Cr(III) is micronutrient that is important in biological activities
nvolved in potentiating lipids and insulin and in carbohy-
rate metabolism [7–10]. Type II diabetes, cardiovascular
∗ Corresponding author. Tel.: +86 538 8246287; fax: +86 538 8241419.
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214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open ac
icenses/by-nc-nd/4.0/).diseases, and nervous system disorders have been asso-
ciated with Cr(III) deﬁciency [8,11]. Thus, patients with
glucose, insulin, lipid, and related abnormalities have been
afﬁliated with insufﬁcient Cr in their diets, and the treat-
ment for these diseases involves the addition of Cr in their
diet [8].
Cr(VI) enters the cell via general anion channels and is
subsequently reduced to Cr(III) and other intermediates
by a series of enzymatically catalyzed reactions. On the
other hand, Cr(III) cannot enter the cell [12–14]. However,
the DNA-damaging effects of Cr(III) have been reported
both in cellular and cell-free systems [15]. Cr(III) negatively
affects enzyme activity, intracellular ATP levels, and oxygen
consumption [16]. The carcinogenic mechanisms of Cr(III)
might be related to its ability to generate hydroxyl radi-
cals ( OH) through the Fenton reaction [17]. Evidence have
shown the trans-generational carcinogenicity of Cr(III) in
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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the descendant of male mice that were intraperitoneally
exposed to chromic chloride (CrCl3) [18], which may  be
correlated to alterations in hormonal signaling [19] and/or
gene expression [20].
The objective of this study is to evaluate the effects
of chromic chloride on chick embryo ﬁbroblast (CEF) via-
bility. The cytotoxic potential of speciﬁc Cr(III) complexes
was determined at the cellular level in terms of DNA dam-
age, alterations in cellular morphology, and changes in
intracellular reactive oxygen species (ROS), mitochondrial
membrane potential (MMP), and intracellular free Ca2+.
The concentrations of CrCl3 at which cell proliferation is
promoted and at which cell death occurs were determined.
By studying these complexes, we expect to gain insights on
the mechanism of metal-mediated cellular damage and the
suitability of adding CrCl3 in pharmaceutical dietary sup-
plements. This study also provides a theoretical basis for
further research.
2. Materials and methods
2.1. Chemicals
All chemicals were of the highest-grade purity available.
CrCl3 was purchased from Aladdin Reagent Database Inc.
DMEM and trypsin were purchased from Sigma–Aldrich,
USA. Newborn calf serum (NCF) was purchased from
Sijiqing Biological Engineering Material (Hangzhou, China).
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), 2,7-dichloroﬂuorescein diacetate (DCFH-
DA), Hoechst 33258 staining, rhodamine 123 (Rh 123),
Fluo-3/AM, and Annexin V/PI detection apoptotic kits
were obtained from Beyotime Institute of Biotechnology
(Jiangsu, China).
2.2. Preparation of CEF cell culture monolayers
The CEF were prepared from 9- to 11-day-old chicken
embryos (Hy-Line Brown LTD, Taiwan, and China). After
removing the head, limbs, and viscera, the embryos were
cut into pieces with sizes between 1 and 2 mm and washed
in PBS. The CEF were prepared by three rounds of trypsin-
isation (0.25%) for 1 min  at 37 ◦C [21]. After ﬁltration, the
CEF were cultured in DMEM with 5% NCF and antibiotics at
37 ◦C with 5% CO2.
2.3. Chemical treatment
CrCl3 was dissolved in the DMEM solution and was
added to the CEF solution to produce ﬁnal concentrations of
0, 0.02, 0.1, 0.5, 2.5, 12.5, and 62.5 M and incubated at 24,
48, and 72 h. Cell viability was tested using the MTT  assay.
2.4. Assessment of cell survival
Cell viability in the culture medium was determined by
the MTT  assay [22]. The cells were seeded at a density of
2 × 105 mL−1, and only 100 L of the DMEM medium con-
taining 2% NCF was added to the 96-well plates. The CEF
were then incubated with CrCl3 at 0, 0.02, 0.1, 0.5, 2.5,rts 2 (2015) 555–562
12.5, and 62.5 M for 24 h, 48 h, and 72 h at 37 ◦C. At pre-
determined time points, 15 L of the MTT  solution was
added into the 96 well plates and incubated at 37 ◦C for 4 h.
The medium was  then removed, and 150 L of dimethyl
sulfoxide (DMSO) was added to each well to dissolve for-
mazan [23,24]. The 96-well culture plate was  agitated for
10 min  on a shaker. The plates were spectrophotometri-
cally evaluated at 570 nm,  and the OD value was  obtained.
The assays were performed three times each.
2.5. Analysis of nuclear morphology
Apoptotic morphological changes in the nuclear chro-
matin were detected by staining with the DNA-binding
ﬂuorochrome Hoechst 33258 (bisbenzimide) [25]. The CEF
cells were seeded into 6-well plates at a cell density of
4 × 105 per well. After incubation with various concen-
trations of CrCl3 (0, 0.02, 0.1, 0.5, 2.5, 12.5, and 62.5 M)
for 48 h, the control and treated cells were washed twice
with PBS and then ﬁxed with 4% paraformaldehyde for
15 min  at room temperature. Subsequently, the cells were
washed three times with PBS and incubated with 5 g/mL
Hoechst 33258 staining solution for 15 min. After three
washes, the cells were viewed using an inverted ﬂu-
orescence microscope (TE-2000-S, NIKON, Japan) at an
excitation wavelength of 352 nm.
2.6. Flow cytometry with Annexin V/PI staining
About 2 × 105 cells/mL were seeded into 6-well plates,
which were then incubated for about 5 h at 37 ◦C.
Subsequently, the cells were incubated with various con-
centrations of CrCl3 (0, 0.02, 0.1, 0.5, 2.5, 12.5, and 62.5 M)
for 48 h. After treatment, the cells were harvested and
washed with PBS. The cells from each sample were sus-
pended in 195 L of 1× Annexin V-FITC binding buffer and
5 L of Annexin V-FITC, and then incubated at room tem-
perature for 10 min. Each sample was then centrifuged at
1000 × g for 5 min, resuspended in 190 L of the binding
buffer, and 10 L of propidium iodide (PI) working solu-
tion was added. The samples were then analyzed via ﬂow
cytometric methods (FCM) [26]. The population was ana-
lyzed using quadrant statistics. The cells in the lower left
quadrant represented living cells, those in the lower right
quadrant represented necrotic cells, those in the upper left
quadrant represented early apoptotic cells, and those in the
upper right quadrant represented late apoptotic cells.
2.7. Measurement of Intracellular ROS
Intracellular ROS was  determined using a ﬂuorescent
DCFH-DA probe [27,28]. The cells were then treated in a
similar manner as that in the previous section. The cells
were washed with PBS and incubated with DCFH-DA at
37 ◦C for 30 min  in the dark. The DCFH-DA was  oxidized toﬂuorescence distribution of 10,000 cells was  determined at
an excitation wavelength of 485 nm and an emission wave-
length of 530 nm by using a FACS Calibur ﬂow cytometer
(Becton Dickinson, USA).
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Table  1
Effects of CrCl3 on the survival of CEF at different time points.
Groups OD values
24 h 48 h 72 h
A 0.436 ± 0.0130 0.461 ± 0.00547 0.422 ± 0.00234
B  0.456 ± 0.188 0.477 ± 0.00872 0.440 ± 0.00560
C  0.467 ± 0.0167# 0.490 ± 0.00445# 0.446 ± 0.00817#
D 0.423 ± 0.0140 0.437 ± 0.0369 0.411 ± 0.00432
E  0.406 ± 0.00489# 0.377 ± 0.0321## 0.317 ± 0.0299##
F 0.365 ± 0.0278## 0.349 ± 0.0317## 0.313 ± 0.0295##
G 0.344 ± 0.0304## 0.340 ± 0.0161## 0.309 ± 0.0199##
Among the groups: A control, B 0.02 M CrCl3, C 0.1 M CrCl3, D 0.5 M CrCl3, E 2.5 M CrCl3, F 12.5 M CrCl3, and G 62.5 M CrCl3. The values for each
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arCl3 concentration tested represent the average as mean± SD (n = 6). Co
# P < 0.05.
## P < 0.01 using one-way ANOVA.
.8. Changes of mitochondrial membrane potential
MMP)
The changes in MMP  were estimated using the ﬂuores-
ent cationic dye Rh123 [29], which can speciﬁcally bind
o mitochondria and has been used in numerous investiga-
ions to estimate MMP  [30] with several modiﬁcations. The
ells were treated in a similar manner as that in the previ-
us section. Then treated cells were harvested, washed, and
ncubated with Rh123 (5 g/mL) in PBS at 37 ◦C for 30 min
n the dark. The cells were then washed twice with PBS, and
he ﬂuorescence was immediately measured at an excita-
ion wavelength of 485 nm and an emission wavelength
f 530 nm by using a FACS Calibur ﬂow cytometer (Becton
ickinson, USA).
.9. Intracellular free Ca2+ measurements
The cells were treated in a similar manner as that in the
revious section. The samples were loaded with the Ca2+
ndicator Fluo-3/AM (1 M;  Beyotime, Jiangsu, China) for
0 min  in the dark at 37 ◦C. The cells were then washed
wice with PBS. The ﬂuorescence intensity distribution of
0,000 cells was determined at an excitation wavelength of
85 nm and an emission wavelength of 530 nm by using a
ACS Calibur ﬂow cytometer (Becton Dickinson, USA). The
uorescence intensity distribution represents intracellular
Ca2+]i.
.10. Statistical analysis
Data are expressed as mean ± SD from at least
hree independent experiments that were performed in
uplicates. Statistical signiﬁcance between groups was
etermined based on one-way analysis of variance. The
PSS 17.0 software was used for statistical analyses. P < 0.05
as considered signiﬁcant.
. Results
.1. Effects of chromic chloride on CEF survivalTable 1 shows the viability of cells treated with different
oncentrations of CrCl3, which was monitored by the MTT
ssay. Lower concentrations of CrCl3 at 0.02 and 0.5 M did the exposed groups (B, C, D, E, F, and G) with the control.
not change CEF viability at any time point. At 0.1 M,  the
effect was more apparent compared with the control sam-
ple (P < 0.05) at three time points. The difference at higher
concentrations of 2.5, 12.5, and 62.5 M were all signiﬁcant
compared with the control group at three time points, and
the cytotoxic effects of the chosen CrCl3 concentrations on
CEF were time- and dose-dependent.
3.2. Effects of CrCl3 on morphologic changes
The effects of various concentrations of CrCl3 were also
detected through morphological observation (Fig. 1). In
Fig. 1a–c, majority of the cells were unaltered, and normal
cell morphology with normal nuclear size and integrity was
observed. However, when the CEF were exposed to higher
concentrations of CrCl3 (2.5 M to 62.5 M),  cell body
shrinkage and highly condensed nuclei were observed
(Fig. 1d–g). Hoechst 33258 was used to assess the change
in DNA and nuclear structures (Fig. 1A–G). Almost no
apoptotic nuclei were found in the cells of the control
group. At lower concentrations of Cr(III) (0.02 and 0.1 M)
(Fig. 1A–C), the nuclei were large and regular, whereas
at higher concentrations of Cr(III) (2.5–62.5 M),  most of
the nuclei were condensed, bright, and had a half-moon
form, which are characteristics of apoptotic dead cells
(Fig. 1D–G). In short, the nuclei of apoptotic cells were
all signiﬁcantly damaged compared with those of intact
cells.
3.3. Effects of CrCl3 on apoptosis induction
Cell apoptosis was investigated via ﬂow cytometry by
using an Annexin V-FITC apoptosis detection kit (Beyotime,
Jiangshu, China). The cytometric analysis results reveal
that at lower concentrations of CrCl3 (0.02 and 0.1 M),
CEF apoptosis was inhibited, whereas at higher concentra-
tions of CrCl3 (2.5, 12.5, and 62.5 M),  CEF apoptosis was
observed (Fig. 2). As shown in Table 2, the percentage of
live cells exposed to lower concentrations of CrCl3 (0.02
and 0.1 M)  signiﬁcantly increased from 60.86% to 63.55%
(P < 0.05). Similarly, signiﬁcant differences were observed
in the percentages of apoptotic and necrotic cells at a CrCl3
concentration of 0.1 M.  However, when the cells were
exposed to higher concentrations of CrCl3 (0.5, 2.5, 12.5,
and 62.5 M)  for 48 h, the percentage of apoptotic cells
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Fig. 1. Effects of Cr(III) on the morphologic changes. Control (a, A), 0.02 M CrCl3 (b, B), 0.1 M CrCl3 (c, C), 0.5 M CrCl3 (d, D), 2.5 M CrCl3 (e, E),
12.5  M CrCl3 (f, F), 62.5 M CrCl3 (g, G). Cellular morphology was observed with light microscope (a–g). In addition, nuclear morphology was observed by
es of nucﬂuorescence microscope after stained with bisbenzimide (A–G). The chang
CrCl3 are evident. a–g, A–G = original magniﬁcation × 200.
signiﬁcantly increased from 34.89% to 46.99% (P < 0.01) and
dose-dependent cytotoxic effects were observed.3.4. Effects of CrCl3 on intracellular ROS levels in CEF
A ﬂuorescent DCFH-DA probe was used to test the
generation of intracellular ROS. The ﬂuorescence of the
Table 2
Percent of live cells, necrotic cells and apoptotic cells in chicken embryo
ﬁbroblast treated with Cr(III) (n = 4).
Groups Percent of live
cells
Percent of
apoptotic cells
Percent of
necrotic cells
A 60.86 ± 0.44 34.89 ± 0.17 4.86 ± 0.53
B  61.26 ± 0.40# 34.41 ± 0.62 4.33 ± 0.35
C  63.55 ± 0.65## 30.83 ± 0.89## 5.63 ± 0.63#
D 58.79 ± 0.80## 36.69 ± 0.52## 4.53 ± 0.50
E  52.31 ± 0.65## 42.19 ± 0.72## 5.51 ± 0.21#
F 47.21 ± 0.15## 47.62 ± 0.35## 5.17 ± 0.30
G  44.55 ± 0.31## 46.99 ± 0.37## 8.46 ± 0.38##
A control, B 0.02 M CrCl3, C 0.1 M CrCl3, D 0.5 M CrCl3, E 2.5 M CrCl3,
F  12.5 M CrCl3, and G 62.5 M CrCl3.
# P < 0.05.
## P < 0.01 using one-way ANOVA.lei fragmentation with condensed chromatin exposed in 2.5 M–62.5 M
cells was  examined on FCM at an excitation wavelength
of 480 nm and an emission wavelength of 530 nm.  As
shown in Fig. 3, the ROS level in the cells decreased
when incubated at lower concentrations of CrCl3 (0.02
and 0.1 M)  for 48 h. At a CrCl3 concentration of 0.1 M,
the level of ROS was  signiﬁcantly lower (P < 0.01) than
that of the control group. On the other hand, the level
of ROS increased when the cells were exposed to higher
concentrations of CrCl3 (0.5, 2.5, 12.5, and 62.5 M)  for
48 h, and the increase occurred in a dose-dependent man-
ner. The mean ﬂuorescence intensity was signiﬁcantly
higher than that of the control group (287.75 ± 1.78,
P < 0.01).
3.5. Changes in MMP in CEF
As shown in Fig. 4, the CEF treated with lower concen-
trations of CrCl3 (0.02, 0.1, and 0.5 M)  for 48 h showed
a signiﬁcant increase in MMP  except at 0.5 M (P < 0.01).
On the other hand, the MMP  signiﬁcantly decreased after
the cells were treated with higher concentrations of CrCl3
(2.5, 12.5, and 62.5 M)  for 48 h. The decrease occurred in
a concentration-dependent manner (P < 0.01).
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Fig. 2. Effects of Cr(III) on distribution of apoptotic cells. A control, B 0.02 M CrCl3, C 0.1 M CrCl3, D 0.5 M CrCl3, E 2.5 M CrCl3, F 12.5 M CrCl3, and G
62.5  M CrCl3. Q1: Early/primary apoptotic cells (Annexin V+/PI−); Q2: Late/secondary apoptotic cells (Annexin V+/PI+); Q3: Live cells (Annexin V−/PI−);
Q4:  Necrotic cells (Annexin V−/PI+).
560 M. Liu et al. / Toxicology Reports 2 (2015) 555–562
Fig. 3. Effects of Cr(III) on intracellular ROS level in CEF. The intracellular
Fig. 5. Effects of Cr(III) on Intracellular [Ca2+]i. The statistical interpre-
tation of data expressed as mean ± SD (n = 4). Cells were treated with: AROS as mean ± SD (n = 4). Cells were treated with: A control, B 0.02 MCrCl3, C 0.1 M CrCl3, D 0.5 M CrCl3, E 2.5 M CrCl3, F 12.5 M CrCl3, and
G  62.5 M CrCl3 for 48 h. (#P < 0.05 vs. control and ##P < 0.01 vs. control).
3.6. Effects of CrCl3 on Intracellular [Ca2+]i
As shown in Fig. 5, after treatment with different
concentrations of CrCl3 for 48 h, exposure to lower concen-
trations of CrCl3 (0.1 M)  resulted in a marked decrease in
intracellular [Ca2+]i (P < 0.01). On the other hand, at higher
concentrations of CrCl3 (2.5, 12.5, and 62.5 M)  intracellu-
lar [Ca2+]i was  signiﬁcantly enhanced (P < 0.01).
4. Discussion
Regarding the effect of chromium, researchers mainly
studied lymphocytes [31,32], bacterial cells [33], and der-
mal  ﬁbroblasts [34]. However, in these animal studies, the
effects of chromium on animal cells are rarely reported.
Thus, this study aims to determine the effect of CrCl3 on
CEF viability at speciﬁc CrCl3 concentrations. The selected
dose range of CrCl3 in the present study was 0.02–62.5 M,
which is within the acceptable limit for human consump-
tion, speciﬁcally for pills that contain Cr(III) picolinate [35].
The cellular viability test results, in which 2 × 105 cells
were incubated with different concentrations of CrCl3 for
Fig. 4. The changes of MMP  in CEF. The statistical interpretation of data
expressed as mean ± SD (n = 4). Cells were treated with: A control, B
0.02 M CrCl3, C 0.1 M CrCl3, D 0.5 M CrCl3, E 2.5 M CrCl3, F 12.5 M
CrCl3, and G 62.5 M CrCl3 for 48 h. (#P < 0.05 vs. control and ##P < 0.01 vs.
control).control, B 0.02 M CrCl3, C 0.1 M CrCl3, D 0.5 M CrCl3, E 2.5 M CrCl3,
F  12.5 M CrCl3, and G 62.5 M CrCl3 for 48 h (#P < 0.05 vs. control and
##P < 0.01 vs. control).
24, 48, and 72 h, show that at lower concentrations of CrCl3
(0.02, 0.1, and 0.5 M),  cell toxicity was  not observed at
any time. At a CrCl3 concentration of 0.1 M,  cell prolif-
eration was signiﬁcantly promoted (P < 0.05). However, at
higher concentrations of CrCl3 (2.5, 12.5, and 62.5 M), cell
toxicity was  observed at three time periods (P < 0.01). The
result also shows that at incubation with higher concen-
trations of CrCl3 induced cell death, which is caused by
both incubation time and metal concentration. The fur-
ther experiments were performed to investigate if different
concentrations of CrCl3 lead to cell proliferation or necro-
sis. As shown in Table 2, cell death induced by higher
concentrations of CrCl3 is mediated by two  mechanisms,
namely, apoptotic and necrotic. The amount of apoptotic
cells induced by higher concentrations of CrCl3 signiﬁcantly
increased. Moreover, the number of necrotic cells and the
cellular morphology conﬁrm that the necrotic mechanism
is responsible for cell death. By comparison, cell death is
caused by the apoptotic mechanism at higher concentra-
tions of CrCl3.
Cellular morphology was  assessed through Hoechst
33258 staining. Apoptotic morphological changes such as
DNA fragmentation were also observed compared with
intact cells. This result is consistent with that obtained from
ﬂow cytometric analysis.
In this study, the CEF incubated at higher concentra-
tion of CrCl3 generated a signiﬁcant amount of ROS (Fig. 3).
This result further proves that oxidative stress has a key
function in cell toxicity induced by CrCl3, and the reverse
can be said at lower concentrations of CrCl3. Intracellu-
lar ROS is mainly produced in the mitochondria, which
seriously damages the mitochondria [36]. Studies have
demonstrated that intracellular ROS can regulate the initi-
ation of apoptotic signaling [37,38]. In addition, excessive
amounts of ROS may  directly induce cell damage by oxidiz-
ing and inactivating proteins and lipids and by changing
the normal cellular signaling pathways [39–41]. In the
present study, the changes in the mitochondria could affect
the intracellular ROS levels in CEF because CrCl3 changes
the MMP,  which is consistent with the intracellular ROS
levels. The increasing amount of ROS generated from the
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ntermembrane space can lead to mitochondrial dysfunc-
ion and contributes to cell death [42]. Studies have clearly
hown that ROS is a associated with the decrease in MMP
43]. These results show that MMP  has an important func-
ion in apoptosis induced by CrCl3.
In addition, intracellular [Ca2+]i had an abnormal
anifestation when the CEF was treated at higher concen-
rations of CrCl3 (Fig. 5). These results also conﬁrm that
nother important mechanism of cell apoptosis is caused
y abnormal Ca2+ homeostasis when exposed to CrCl3.
emoving Ca2+ from the cytosol across the plasma mem-
rane requires sufﬁcient ATP [44,45]. Furthermore, normal
itochondria generates ATP if MMP  breakdown results in
 decrease in ATP levels [46]. Moreover, oxidative dam-
ge easily affects the mitochondria. Therefore, treatments
ith higher concentrations of CrCl3 result in mitochondrial
ysfunction, ROS overproduction. These results also lead to
ntracellular calcium overload.
. Conclusions
The experimental results show that CrCl3 concentra-
ions below 0.5 M do not have harmful effects on the
EF, whereas higher concentrations of CrCl3 (2.5, 12.5, and
2.5 M)  affects the CEF mainly through oxidation damage,
hich leads to cell apoptosis, and occurs in a dose- and
ime-dependent manner. In conclusion, chromic chloride
ffected the viability of chick embryo ﬁbroblast.
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